Results 101 to 110 of about 15,790 (257)

Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy [PDF]

, 2004
Victor J. Verwaal, Harm van Tinteren, Serge van Ruth, F.A.N. Zoetmulder   +3 more
openalex   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

Journal of Visceral Surgery, 2014
Ovarian cancer remains the fourth leading cause of cancer death in women in France. It is all too often diagnosed at an advanced stage with peritoneal carcinomatosis (PC), but remains confined to the peritoneal cavity throughout much of its natural history.
J-M Classe, Sebastien Gouy, Olivier Glehen, Christophe Pomel, Naoual Bakrin, G. Chene   +5 more
openaire   +3 more sources

Efficacy and safety of intraperitoneal chemotherapy for pancreatic cancer

BMC Surgery
Pancreatic cancer is a highly aggressive cancer with unfavorable prognosis despite the therapeutic interventions. Intraperitoneal chemotherapy has recently shown potential outcomes in the presence of peritoneal metastases.
Dorsa Safari, Mohammad Fakhrolmobasheri, Saeed Soleymanjahi   +2 more
doaj   +1 more source

Применение гипертермической химиоперфузии в лечении перитонеального карциноматоза (обзор) [PDF]

, 2016
Использование циторедуктивной хирургии (CRS) и HIPEC (Hyperthermic intraperitoneal chemotherapy) делает перитонеальный карциноматоз потенциально излечимым заболеванием.
Дубинина, В.Г., Максимовский, В.Е., Пыхтеева, Е.Д.   +2 more
core  

Peritoneaalse kartsinomatoosi kombineeritud ravi tsütoreduktiivse operatsiooni ja intraperitoneaalse keemiaraviga [PDF]

, 2009
Levik kõhukelmele on seedetrakti ja günekoloogiliste kaugelearenenud kasvajate või nende taaspuhkemise üks sagedasi ilminguid. Peritoneaalse kartsinomatoosi tervistava ravi võimalused on olnud üsna piiratud ja prognoos seetõttu halb.
Arak, Andrus
core   +2 more sources

A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis [PDF]

, 2005
Joerg Pelz, J Doerfer, Werner Hohenberger, Thomas Meyer   +3 more
openalex   +1 more source

Гіпертермія в онкології: досягнення та оригінальні методики [PDF]

, 2006
Гіпертермія (ГТ) — один з ефективних модифікаторів протипухлинної терапії, усе більше привертає до себе увагу онкологів. Узагальнено відомості щодо методів проведення як загальної, так і локальної ГТ у поєднанні з хіміотерапією, показань та протипоказань
Ганул, А.В., Ганул, В.Л., Осинський, Д.С., Шевченко, А.І.   +3 more
core  

A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in Rats [PDF]

, 2007
Flor Aarts, T Hendriks, Otto C. Boerman, Manuel J. Koppe, Wim J.G. Oyen, Robert P. Bleichrodt   +5 more
openalex   +1 more source

Bases and foundations of the treatment of peritoneal carcinomatosis: Review article [PDF]

, 2016
Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis.
Barrios Sánchez, P., Castro Mesta, Julio Fernando, González Guerrero, Juan Francisco, Villarreal Cavazos, Gerardo   +3 more
core  

MODERN STRATEGY IN TREATMENT OF PERITONEAL CARCINOMATOSIS

Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2017
Peritoneal carcinomatosis (PC) is a common manifestation of progression in peritoneal and gynecologic malignancies. Current primary strategy in treatment of PC is the concept of regional influence by the way of cytoreductive surgery and intraperitoneal ...
A. A. Zakharenko, D. A. Zaitcev, M. A. Belyaev, A. A. Trushin, O. A. Ten, A. S. Natkha, K. N. Vovin, V. A. Rybalchenko   +7 more
doaj   +1 more source